BIT will display two innovative instrument solutions at the ECCMID 2018 congress taking place April 21-24 at the IFEMA Convention Center in Madrid, Spain.
My name is Mona Amin, working at BIT Group USA. One of my passions is to “Give Back” to my community and make a positive impact in peoples lives.
On 1st of September Mark Rahman joined BIT as Group Chief Financial Officer. Mark is an experienced global finance and strategy executive who has worked extensively across the world in both the production and service sectors in the healthcare, mining, chemical and retail industries.
In the Molecular Diagnostic (MDx) instrument development market, we are seeing many more opportunities for single point or small multiplex assays in small instruments. These Point of Care or Point of Collection (POC) opportunities are coming from two fronts.
Meet Global BIT Business Development Team at MedLab 2018 in Dubai. The 2018 MEDLAB held in Dubai, UAE, will start on February 5-8. With more than 600 exhibitors from 40 countries, more than 25,000 international attendees and 17 multi-disciplinary CME-accredited conferences, the show is known for being the largest multi-specialty laboratory expo worldwide.
BIT is glad to announce that Dr. Philippe Grandjean has joined as Vice President of Business Development Europe.
The AMP Annual Meeting is recognized as the premier gathering for molecular professionals as they seek to obtain critical, analytical patient care intelligence.
Dr. Josée Naegelen joins BIT as Vice President of Global Hematology Business Development Montpellier, France, Nov 6, 2017 – BIT…
Meet global BIT Business Development team at MEDICA 2017 The 2017 MEDICA World Forum for Medicine held in Duesseldorf, Germany,…
Joe Ryan presents current market trends in Molecular Diagnostics Oct 6, 2017, Schwalbach, Germany – BIT Group continues its proactive…